Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.

Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.

Item
http://www.wikidata.org/entity/Q34520835
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapyA phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE).More potent lipid-lowering effect by rosuvastatin compared with fluvastatin in everolimus-treated renal transplant recipients.Interaction of innovative small molecule drugs used for cancer therapy with drug transporters.Future immunosuppressive agents in solid-organ transplantation.Everolimus: a proliferation signal inhibitor with clinical applications in organ transplantation, oncology, and cardiology.Inhibitors of mTOR.Everolimus: preventing organ rejection in adult kidney transplant recipients.Ethnic variability in the plasma exposures of OATP1B1 substrates such as HMG-CoA reductase inhibitors: a kinetic consideration of its mechanism.Drug-drug interactions that interfere with statin metabolism.Interaction of sirolimus and everolimus with hepatic and intestinal organic anion-transporting polypeptide transporters.The use of everolimus in renal-transplant patientsPharmacokinetic interaction between verapamil and everolimus in healthy subjects.Physiologically based pharmacokinetic models for everolimus and sorafenib in mice.Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.
P2860

Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.

Item
http://www.wikidata.org/entity/Q34520835
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@ast
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@en
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@nl
type
label
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@ast
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@en
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@nl
prefLabel
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@ast
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@en
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Pharmacokinetic and pharmacody ...... oadministered with everolimus.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698